StockDrifts LogoStockDrifts

HLB Life Science 067630

Company
HLB생명과학HLB Life Science
Insiders
3
Buys
6
Total Value
—
Avg Return
—
Last Filing
2026-06-30

HLB Life Science (067630) has 6 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. The earliest filing StockDrifts holds for HLB Life Science is dated 2023-03-31; the most recent is 2026-06-30. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-30BUYMarket Buy
유춘성
Yu Chun-seong
vice president1.5K---
2026-06-30BUYMarket Buy
백윤기
Baek Yoongi
CEO3.3K---
2026-06-29BUYMarket Buy
백윤기
Baek Yoongi
CEO88---
2026-06-26BUY신규보고
정성욱
Seongwook Jeong
moving1.8K---
2026-06-26BUYMarket Buy
백윤기
Baek Yoongi
CEO3.0K---
2026-06-26BUYMarket Buy
이길현
Lee Gil-hyeon
moving1.0K---
2026-06-25BUYMarket Buy
유춘성
Yu Chun-seong
vice president2.0K---
2026-06-25BUY신규보고
이길현
Lee Gil-hyeon
moving1.0K---
2026-06-25BUY신규보고
백윤기
Baek Yoongi
CEO3.0K---
2026-06-24BUY신규보고
유춘성
Yu Chun-seong
vice president1.0K---
2024-12-16SELL풋옵션권리행사에따른주식처분
HLB
--2.3M₩9,970+60.5%₩22.6B ($15.7M)
2024-12-10BUY전환사채의권리행사
조용호
Cho Yong-ho
president3.2M₩9,940-60.4%₩31.8B ($22.1M)
2024-12-10SELL전환권등소멸
조용호
Cho Yong-ho
president-3.2M₩9,940+60.4%₩31.8B ($22.1M)
2024-11-07BUY행사가액조정
조용호
Cho Yong-ho
president122.4K₩8,500-53.7%₩1.0B ($722K)
2024-06-25SELL기타
HLB
--1.0M₩9,270+57.5%₩9.3B ($6.5M)
2024-06-25BUY행사가액조정
조용호
Cho Yong-ho
president76.8K₩9,270-57.5%₩712M ($495K)
2024-06-25BUY유상신주취득
HLB
-1.0M₩9,270-57.5%₩9.3B ($6.5M)
2024-06-25BUY행사가액조정
HLB
-56.3K₩9,270-57.5%₩522M ($362K)
2024-06-17BUY행사가액조정
HLB
-1.5K₩8,860-55.6%₩13M ($9K)
2024-05-28SELL장외매도
HLB
--1.0M₩10,020+60.7%₩10.1B ($7.0M)
2024-05-22BUY기타
HLB
-2.0M₩8,760-55.1%₩17.6B ($12.3M)
2023-03-31BUY기타
HLB
-1₩10,660-63.1%₩11K ($7)

Frequently asked questions

Who has been buying HLB Life Science stock?
3 distinct insiders have filed 6 disclosed insider purchases in HLB Life Science (067630), most recently on 2026-06-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does HLB Life Science have?
HLB Life Science has 6 buy-side and 0 sell-side disclosures on record, spanning 2023-03-31 to 2026-06-30.
Where does StockDrifts get HLB Life Science insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for HLB Life Science. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.